Explaining Retractions

Editors and publishers should use a standardized form to detail why they are pulling papers from the scientific literature.

Written byEvelyne Decullier and Hervé Maisonneuve
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© ISTOCK.COM/JANE_KELLY

Retractions are on the rise. In the early 2000s, only about 30 retraction notices appeared annually; in the last five years, that number has jumped to around 500 (Nature, 478:26-28, 2011). And since the launch of Retraction Watch in August 2010, there has been a growing interest among publishers, editors, authors, and the press in manuscripts that are pulled from the literature. Previously, retractions had no visibility, as they were published without any warning. Retraction Watch provides a central location where researchers can keep track of flawed papers and often learn a little about the stories underlying their retractions.

While it’s good that this problem is receiving more attention, this trend highlights another important issue: often little or no information is given about the reasons ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform